- Philip Salem, 82, developed a most cancers therapy referred to as ICtriplex, which mixes immunotherapy, chemotherapy and focused remedy.
- He mentioned the tactic led to finish remission in 50% of sufferers, in comparison with lower than 30% with typical therapies.
Cancer sufferers come from everywhere in the world to our Houston oncologists who’ve developed a cutting-edge therapy that achieves full remission in 50% of sufferers.
Philip Salem, 82, has developed a breakthrough most cancers therapy referred to as ICtriplex, which mixes immunotherapy, chemotherapy and focused remedy.
“I’ve been in most cancers drugs for 55 years. What we’re seeing now because of ICTriplex is one thing I’ve by no means seen earlier than,” Salem advised ABC7.
The 82-year-old oncologist, who’s on the forefront of most cancers analysis, printed his findings in June 2022 within the Journal of the American Society of Clinical Oncology.
The compelling outcomes of his analysis attracted determined sufferers from everywhere in the world, who traveled 1000’s of miles to Houston, Texas, looking for hope and the probabilities supplied by this breakthrough therapy.
Bianca Grado, a affected person who traveled to Houston from Italy, mentioned she first realized about Dr. Salem a few yr in the past when her most cancers had progressed and unfold.
“I began therapy in Italy, however sadly the outcomes weren’t good and the illness was continuously progressing.”
Salem mentioned Grado, who has been battling the tough illness for 3 years, is now in full remission.
“When I first got here right here, I used to be in numerous ache, however inside the first month, the ache was already gone,” mentioned Petra, a most cancers affected person who referred to as the therapy a miracle.
He mentioned Salem’s oncology middle is the one one which makes use of a mix of immunotherapy, chemotherapy and focused remedy within the administration of superior cancers.
“When we take sufferers who’re advised by main most cancers facilities to go residence and die, we’ve an entire remission price of fifty to 60 %.”
“Zero % versus 50 %, it is a straightforward alternative,” mentioned most cancers affected person Marco Pragman.
Salem’s analysis on ICTriplex was printed within the Journal of the American Society of Clinical Oncology, some of the influential journals within the discipline.
He studied 41 sufferers with a number of sorts of most cancers, together with lung, pancreatic, colorectal, and breast, all at superior phases.
The total remission price, which takes under consideration sufferers with each partial and full remissions, was a formidable 90%.
In distinction, conventional therapies usually have remission charges of lower than 30%, he mentioned.
He advised the Houston Chronicle in 2022: “And surprisingly, this mixture turned out to be very efficient in a variety of most cancers diagnoses.” He just isn’t restricted to at least one prognosis or one tumor. ”
This breakthrough therapy is more practical for sufferers with lung and pancreatic most cancers, with an entire response price of 70 %.
Professor Salem mentioned: “We suggest this therapy as a first-line, first-line therapy as a result of it was so efficient for the lungs and pancreas.”
Patients are grateful to Salem and see him as a beacon of hope within the struggle towards what is taken into account humanity’s most tough illness.
Ellie Moore was identified with stage 4 lung most cancers 10 years in the past and has been in remission since 2019.
“I knew I needed to struggle as laborious as I might. Dr. Salem assured me that we’d not quit,” she mentioned.
“Since I dwell in Houston, I used to be capable of depart the workplace for therapy and return to work the identical day,” she added.
“I like Dr. Salem. He’s my hero,” Grado mentioned with nice pleasure.